SCHEMBL10171416

SCHEMBL10171416

CCCCCCON(CC(=O)O)CC(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 1/20 0.49
BLM P54132 1/20 0.49
GPR84 Q9NQS5 7/20 0.45
PPARG P37231 7/20 0.45
PPARD Q03181 7/20 0.45
PPARA Q07869 7/20 0.45
HDAC11 Q96DB2 5/20 0.45
TSHR P16473 4/20 0.45
PTPN1 P18031 3/20 0.45
ALDH1A1 P00352 2/20 0.45
TLR2 O60603 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
FABP4 P15090 2/20 0.45
SLC22A6 Q4U2R8 1/20 0.45
SLC22A8 Q8TCC7 1/20 0.45
MEN1 O00255 1/20 0.45
ESR1 P03372 1/20 0.45
ALOX15 P16050 1/20 0.45
PDE4A P27815 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL345325 0.92 PLA2G2A (0.46) PLA2G2ABLMGPR84PPARGPPARD
SCHEMBL8525433 0.89 GPR84 (0.48) PLA2G2ABLMGPR84PPARGPPARD
SCHEMBL8198217 0.89 GPR84 (0.48) PLA2G2ABLMGPR84PPARGPPARD
SCHEMBL10171287 0.83 BLM (0.37) PLA2G2ABLMGPR84PPARGPPARD
SCHEMBL10171277 0.79 NAAA (0.48) TSHRALDH1A1ESR1NAAACES2
SCHEMBL8048010 0.78 BLM (0.42) BLMTSHRTDP1ALOX15HSD17B10
SCHEMBL4765473 0.77 TSHR (0.41) PLA2G2ABLMGPR84TSHRALDH1A1
SCHEMBL4982156 0.75 PLA2G2A (0.42) PLA2G2ABLMGPR84PPARGPPARD
SCHEMBL3260596 0.74 PLA2G2A (0.41) PLA2G2ABLMGPR84PPARGPPARD
SCHEMBL7717708 0.74 BLM (0.37) PLA2G2ABLMTSHRTDP1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101325-B2 Azo compound, curable composition, color filter, and method of producing the same FUJIFILM CORPORATION (JP) 2012-01-24 US disclosed
US-20090075188-A1 AZO COMPOUND, CURABLE COMPOSITION, COLOR FILTER, AND METHOD OF PRODUCING THE SAME FUJIFILM CORPORATION (JP) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090075188-A1 AZO COMPOUND, CURABLE COMPOSITION, COLOR FILTER, AND METHOD OF PRODUCING THE SAME CRY1, RB1, CRY2 PLA2G2A 4627/4885BLM 1463/4885GPR84 3195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.